1. The ED as the Gatekeeperin Transitions of Care James Hoekstra, MD Professor and ChairmanDepartment of Emergency MedicineWake Forest University Health Sciences 2. Dr. Hoekstra’s…

Slide 1PROTECT AF PROTECT AF trials Randomized Prospective Trial of Percutaneous LAA Closure vs Warfarin for Stroke Prevention in AF David Holmes, MD;Vivek Reddy, MD; Zoltan…

Slide 1Evidence-Based Management of Anticoagulant Therapy ----- Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-…

Slide 1Journal Club 17/09/13 Rob Morton Slide 2 Heliox Therapy in Bronchiolitis: Phase III Multicentre double blind RCT Chowdhury et al. Pediatrics 2013; 131:661-669 Slide…

Slide 1Oxford The John Radcliffe Hospital Multi-vessel disease… Le Mans implications Dr Adrian Banning Slide 2 Multi-vessel disease… Le Mans - implications ? Lemans trial…

Slide 1Transitional Care Management Billing Codes: What are they? And what do they mean for Pharmacists? Kathleen Pincus, PharmD, BCPS University of Maryland School of Pharmacy…

1.PROTECT AF Trial: Randomized Prospective Trial of Percutaneous LAA Closure vs Warfarin for Stroke Prevention in AF ACC & i2 Summit 2009 David Holmes, MD Vivek Reddy,…

1. © Nuffield Trust Inner North West London Integrated Care Pilot – year one evaluation 8 July 2013 Holly Holder Fellow in health policy Ian Blunt Senior Research Analyst…

1. A Report from ATAMarch 15, 2012 Jonathan LinkousCEO, American TelemedicineAssociation 2. • Federal Policy• State Policy• ATA Activities 3. Federal PolicyTop 3 Easy…

1. Individualization of Cycle ControlDr. Milton LeongMDCM DSc (McGill)Director, IVF Center, HKSHSpecialist in Reproductive MedicineAdjunct Professor, OBS-GYN, McGill University…